Emerging role of long non-coding RNAs in cisplatin resistance.

Hu, Yang; Zhu, Qiong-Ni; Deng, Jun-Li; Li, Zhi-Xing; Wang, Guo; Zhu, Yuan-Shan

Hu, Yang; Zhu, Qiong-Ni; Deng, Jun-Li; Li, Zhi-Xing; Wang, Guo; Zhu, Yuan-Shan.

Afiliación

Hu Y; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Zhu QN; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China.
Deng JL; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Li ZX; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China.
Wang G; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Zhu YS; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, People's Republic of China.

Onco Targets Ther ; 11: 3185-3194, 2018.

Article en En | MEDLINE | ID: mdl-29881292

Palabras clave

cancer; chemoresistance; cisplatin; lncRNAs

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2018 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google